StonvexLoading…
StonvexStonvexStonvexCore line items from IQV's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $16.31B | $15.40B | $14.98B | $14.41B |
Operating Income | $2.18B | $2.20B | $1.98B | $1.80B |
Net Income | $1.36B | $1.37B | $1.36B | $1.09B |
EPS (Diluted) | $7.84 | $7.49 | $7.29 | $5.72 |
Total Assets | $29.94B | $26.90B | $26.68B | $25.34B |
Total Liabilities | $23.31B | $20.83B | $20.57B | $19.57B |
Cash & Equivalents | $1.98B | $1.70B | $1.38B | $1.22B |
Free Cash Flow OCF − CapEx | $2.05B | $2.11B | $1.50B | $1.59B |
Shares Outstanding | 169.60M | 176.10M | 181.50M | 185.70M |